Abstract:Li-Yu Chen, 1 Chen-Yu Wang, 1, 2 Chi-Ying Lin, 3 Ming-Jui Tsai, 3 Wei-Hsun Shen, 1 Pei-Jhih Li, 1 Lin-Chu Liao, 1 Chih-Fen Huang, 4, 5 Chien-Chih Wu 4 1 Department of Pharmacy, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 2 National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan; 3 Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 4 Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan; 5 School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan Correspondence: Chien-Chih Wu, Department of Pharmacy, National Taiwan University Hospital, 7 Chung Shan S. Road, Taipei, Taiwan, Email ; Background: In the field of postoperative care, infections caused by Gram-positive bacteria pose a major clinical challenge. Vancomycin is a key therapeutic agent whose efficacy is greatly influenced by renal function, particularly by augmented renal clearance (ARC). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rate (eGFR) is an easy and commonly used method to predict ARC; however, it is not well studied to determine vancomycin dose. In this study, we examined the effectiveness of the CKD-EPI equation in determining ARC and optimizing the dose of vancomycin for surgical ward patients. Methodology: A retrospective observational study was conducted to examine 158 surgical ward patients receiving vancomycin. Data on demographics, medical history, and vancomycin dosing were collected. Renal function was evaluated using the CKD-EPI equation, with ARC defined as eGFR ≥ 96.5 mL/min/1.73 m 2 . Vancomycin pharmacokinetics were calculated using the ClinCalc tool. Results: ARC was in 54% of the patients. Compared with patients without ARC, those with ARC were younger and had lower serum creatinine levels. They also required higher vancomycin doses but had lower trough concentrations and 24-hour area-under-the-curve values. A significant correlation was observed between eGFR and vancomycin clearance, with eGFR > 96.5 mL/min/1.73 m 2 necessitating higher vancomycin doses (> 45 mg/kg/day) to achieve the desired area under the curve to minimum inhibitory concentration ratio. Conclusion: For surgical ward patients with CKD-EPI eGFR ≥ 96.5 mL/min/1.73 m 2 , a vancomycin dosage of > 45 mg/kg/day may be recommended to reach effective therapeutic levels. Overall, this study emphasizes the importance of tailoring vancomycin therapy depending on renal function to ensure efficacy and mitigate the risk of antimicrobial resistance in surgical ward patients. Keywords: augmented renal clearance, vancomycin, surgery Postoperative infection is a common complication of surgery, which may prolong hospitalization and affect prognosis. 1 Gram-positive bacteria are often involved in postoperative infections. 2 With the emergence of drug-resistant strains, vancomycin plays a key role in combating infections caused by Gram-positive bacteria, particularly by Staphylococcus aureus . 3–5 The pharmacokinetic/pharmacodynamic (PK/PD) target of vancomycin is defined as the ratio between the area under the curve (AUC) and the minimum inhibitory concentration (MIC), with an optimal target range of 400 to 600 to ensure efficacy and reduce nephrotoxicity. 4 Optimizing the PK/PD target of antibiotics can improve clinical outcomes. 6 AUC/MIC monitoring is primarily recommended for serious methicillin-resistant Staphylococcus aureus (MRSA) infections, such as bacteremia, infective endocarditis, and pneumonia, due to its stronger correlation with clinical outcomes. 4 It is also preferred for patients at high risk of nephrotoxicity, including critically ill patients, patients with unstable renal function, and those on prolonged vancomycin therapy. 4 Trough-only monitoring is no longer recommended due to the higher likelihood of achieving an AUC/MIC >400 with trough concentrations between 10 and 15 mg/L, and the increased risk of nephrotoxicity when trough concentrations exceed 15 mg/L. 7,8 Moreover, numerous studies have demonstrated that AUC-guided monitoring reduces the risk of nephrotoxicity compared to trough-only monitoring. 9 Currently, only for patients undergoing hemodialysis, pre-dialysis concentrations with a target range of 15–20 mg/L are used instead of targeting AUC/MIC. 10 Therefore, identifying the factors affecting the PK/PD target and promptly adjusti -Abstract Truncated-

A Higher Dose of Vancomycin is Needed in Critically Ill Patients with Augmented Renal Clearance

The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients

Clinical study of vancomycin for appropriate dosing in severe infective patients with augmented renal clearance

Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance

Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients

Association between Augmented Renal Clearance and Inadequate Vancomycin Pharmacokinetic/Pharmacodynamic Targets in Chinese Adult Patients: A Prospective Observational Study

Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy

Population pharmacokinetics and dosing optimization of vancomycin in infants, children and adolescents with augmented renal clearance

An individualized administration model of vancomycin in elderly patients with sepsis and factors influencing augmented renal clearance

Analysis of Vancomycin Concentrations on Critical Patients with High Cre-atinine Clearance Rate

[Study on the Optimization of Administration Regimen of Vancomycin in Critical Patients].

Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer

Relationship between nephrotoxicity and area under the concentration–time curve of vancomycin in critically ill patients: a multicenter retrospective study

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis

Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children

Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?

Target Serum Concentration of Vancomycin May Be Reached Earlier with a Loading Dose

[PK/PD of Vancomycin in Patients with Severe Acute Pancreatitis Combined with Augmented Renal Clearance].

A Comparison of Vancomycin Area Under the Curve and Trough Concentration in Specific Populations

Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study